Today’s sophisticated bedside clinical monitoring systems generate data that enable health care providers to improve patient outcomes through informed decisions. There is a lack of randomized clinical trials to demonstrate improved outcomes for patients receiving continuous ST-segment monitoring compared to those who do not. However, there are studies demonstrating that continuous ST-segment monitoring enables early identification of ischemia. In critically ill adults, as many as 90% of all episodes of myocardial ischemia are missed.1
Continuous ST-segment monitoring is underused. We know barriers to the adoption of this technology include the following: lack of awareness of the benefits, lack of education specific to continuous ST-segment monitoring, an increase in nuisance alarms, absence of organizational or unit protocols, and confusion over the most appropriate lead selection.
Investigate and learn the capabilities of your clinical systems related to continuous ST-segment monitoring.
Learn which patients benefit...